CONSTRUCTION OF T CELL HYBRIDOMAS SECRETING ALLOGENEIC EFFECT FACTORKATZ DH; BECH TOLD TE; ALTMAN A et al.1980; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1980; VOL. 152; NO 4; PP. 956-968; BIBL. 39 REF.Article

THE BIOLOGICAL AND BIOCHEMICAL BASIS OF ALLOGENEIC EFFECT FACTOR (AEF) ACTIVITY: RELATIONSHIP TO T CELL ALLOREACTIVITYDELOVITCH TL; PHILLIPS ML.1982; IMMUNOBIOLOGY; DEU; DA. 1982; VOL. 161; NO 1-2; PP. 51-83; BIBL. 90 REF.Article

IN VITRO ANALYSIS OF ALLOGENEIC LYMPHOCYTE INTERACTION. V: IDENTIFICATION AND CHARACTERIZATION OF TWO COMPONENTS OF ALLOGENEIC EFFECT FACTOR, ONE OF WHICH DISPLAYS H-2 RESTRICTED HELPER ACTIVITY AND THE OTHER, T CELL-GROWTH FACTOR ACTIVITYDELOVITCH TL; WATSON J; BATTISTELLA R et al.1981; J. EXP. MED.; ISSN 0022-1007; USA; DA. 1981; VOL. 153; NO 1; PP. 107-128; BIBL. 42 REF.Article

IN VITRO ANALYSIS OF ALLOGENEIC LYMPHOCYTE INTERACTION. II. I-REGION CONTROL OF THE ACTIVITY OF A B-CELL DERIVED H-2-RESTRICTED ALLOGENEIC EFFECT FACTOR AND ITS RECEPTOR DURING B-CELL ACTIVATION.DELOVITCH TL; BIGGIN J; FOON YEE FUNG et al.1978; J. EXPER. MED.; U.S.A.; DA. 1978; VOL. 147; NO 4; PP. 1198-1212; BIBL. 2 P.Article

THE BIOLOGIC EFFECTS OF ALLOGENEIC EFFECT FACTOR ON T LYMPHOCYTES. I: THE MITOGENIC ACTIVITY AND THE AUTONOMOUS INDUCTION OF CYTOTOXIC T LYMPHOCYTES BY AEFALTMAN A; CARDENAS JM; BECHTOLD TE et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 1; PP. 105-113; BIBL. 40 REF.Article

THE BIOLOGICAL EFFECTS OF ALLOGENEIC EFFECT FACTOR (AEF) ON T LYMPHOCYTES. III: INTERFERON DOES NOT CONTRIBUTE TO THE BIOLOGICAL ACTIVITIES DISPLAYED BY AEF ON BOTH T AND B LYMPHOCYTESALTMAN A; CARDENAS JM; WELSH RM JR et al.1980; ANN. IMMUNOL.; FRA; DA. 1980; VOL. 131; NO 3; PP. 335-347; ABS. FRE; BIBL. 27 REF.Article

THE BIOLOGIC EFFECTS OF ALLOGENEIC EFFECT FACTOR ON T LYMPHOCYTES. II: THE SPECIFICITY OF AEF-INDUCED CYTOTOXIC T LYMPHOCYTESALTMAN A; CARDENAS JM; BECHTOLD TE et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 1; PP. 114-120; BIBL. 39 REF.Article

BIOLOGICAL EFFECTS OF ALLOGENEIC EFFECT FACTOR ON T LYMPHOCYTES MANIFESTING PREFERENTIAL LYTIC ACTIVITY AGAINST H-2-IDENTICAL TUMOR CELLSALTMAN A; BECHTOLD TE; CARDENAS JM et al.1979; PROC. NATION. ACAD. SCI.; USA; DA. 1979; VOL. 76; NO 7; PP. 3477-3481; BIBL. 36 REF.Article

Section IV. Preparation, purification, and characterization of antigen-nonspecific lymphokinesMethods in enzymology. 1985, Vol 116, pp 355-619, issn 0076-6879Article